TPD & Induced Proximity Summit Leaderboard
  • Sunday, July 12, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 464

Author

Pharma Journalist 8932 posts 0 comments

Nestlé to acquire Aimmune Therapeutics

Aug 31, 2020
Nestlé and Aimmune Therapeutics, Inc. a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies (Aimmune), have entered into…
Read More...

Seneca Therapeutics Licenses Tumor Endothelial Marker 8 (TEM8) to Enable Better Patient Selection…

Aug 31, 2020
Seneca Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to the development of oncolytic immune-therapeutics based on Seneca Valley Virus (SVV-001), announced the…
Read More...

Vor Biopharma and Metagenomi to Collaborate on Engineered Hematopoietic Stem-Cell Therapies

Aug 31, 2020
Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, and Metagenomi, a gene editing company discovering breakthrough…
Read More...

Rocket Pharmaceuticals Receives FDA Fast Track Designation for RP-L401 Gene Therapy for Infantile…

Aug 27, 2020
Rocket Pharmaceuticals, Inc. a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, announces that the U.S. Food…
Read More...

Piramal to Collaborate with Epirium Bio on Exclusive Integrated Development & Manufacturing…

Aug 27, 2020
Piramal Pharma Solutions announced that the company will be partnering with Epirium Bio on an exclusive manufacturing relationship for new orphan drugs targeting rare diseases with high…
Read More...

BeiGene Announces Exclusive License Agreement for Neutralizing COVID-19 Antibodies Developed by…

Aug 27, 2020
BeiGene, Ltd. and Singlomics Biopharmaceuticals Co., Ltd., announced that the companies have executed an exclusive license agreement for BeiGene to develop, manufacture and…
Read More...

Akers Biosciences and Premas Biotech Announce SARS CoV-2 Positive Proof of Concept Results

Aug 27, 2020
Akers Biosciences, Inc. announced with its partner, Premas Biotech, positive proof of concept results from Animal Studies conducted during a 4 week test of its SARS-CoV-2 vaccine…
Read More...

European Commission signs first Covid-19 vaccine contract with AstraZeneca

Aug 27, 2020
Today, the first contract the European Commission has negotiated on behalf of the EU Member States with a pharmaceutical company entered into force following the formal signature…
Read More...

Ivy Brain Tumor Center and Vivace Therapeutics Collaborate to Test Targeted Agent in Glioblastoma…

Aug 26, 2020
Ivy Brain Tumor Center at Barrow Neurological Institute announced today a new collaboration with Vivace Therapeutics. The Ivy Brain Tumor Center, which employs a bold, early-phase…
Read More...

HiFiBiO Therapeutics Submits IND Application for Fully Human SARS-CoV-2 Neutralizing Antibody for…

Aug 26, 2020
HiFiBiO Therapeutics, a multinational biotherapeutics company focused on the development of novel antibodies for immunomodulation, announced the submission of an Investigational New…
Read More...
Prev Next
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Roche Receives CE Mark for Elecsys Latent TB Test
  • Teva Secures Global Rights to Polpharma’s Ocrevus Biosimilar
  • Samsung Bioepis Partners With Proteina on AI Antibody Drug Discovery
  • Evogene, Tel Aviv University Launch AI Drug Discovery Initiative
  • Wainua Misses Primary Endpoint in ATTR-CM Phase III Trial

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.